NCT02966548 2025-02-17Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid TumorsBristol-Myers SquibbPhase 1 Completed35 enrolled
NCT04112498 2023-04-06A Phase 1, Bioavailability Study of Relatlimab in Combination With NivolumabBristol-Myers SquibbPhase 1 Completed24 enrolled